Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PSMB8 | P28062 | 1/20 | 0.34 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.34 |
| ▸ | KDM6B | O15054 | 1/20 | 0.31 |
| ▸ | KDM5C | P41229 | 1/20 | 0.31 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.31 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.31 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethylene Glycol SCHEMBL2467342 | 0.95 | PSMB8 (0.35) | PSMB8PSMB5KDM6BKDM5CEGLN1 | |
| Urea SCHEMBL4916163 | 0.91 | GPR84 (0.36) | PSMB8PSMB5 | |
| Urea SCHEMBL4905652 | 0.91 | TSHR (0.37) | PSMB8PSMB5 | |
| SCHEMBL43575 | 0.90 | EGLN1 (0.36) | PSMB8PSMB5KDM6BKDM5CEGLN1 | |
| Thioglycolic Acid SCHEMBL27511458 | 0.89 | PSMB8 (0.33) | PSMB8PSMB5KDM6BKDM5CEGLN1 | |
| Ethylene Glycol SCHEMBL999673 | 0.88 | PSMB8 (0.36) | PSMB8PSMB5 | |
| Urethane SCHEMBL4909069 | 0.87 | ALOX15 (0.40) | PSMB8PSMB5 | |
| Di(Hydroxyethyl)Ether SCHEMBL28680315 | 0.86 | PSMB8 (0.33) | PSMB8PSMB5KDM6BKDM5CEGLN1 | |
| Ethylene Glycol SCHEMBL6129445 | 0.85 | TSHR (0.40) | PSMB8PSMB5 | |
| Methoxymethane SCHEMBL7956362 | 0.85 | EGLN1 (0.37) | PSMB8PSMB5KDM6BKDM5CEGLN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080159975-A1 | Hair treatment composition, hair treatment agent and method for treating hair by using the same | SUNBIO, INC. (KR) | 2008-07-03 | — | — | US | claimed |
| EP-1938795-A2 | Hair treatment composition, hair treatment agent and method for treating hair by using the same | Sunbio, Inc. (KR) | 2008-07-02 | — | — | EP | claimed |
| US-20080159975-A1 | Hair treatment composition, hair treatment agent and method for treating hair by using the same | SUNBIO, INC. (KR) | 2008-07-03 | — | — | US | disclosed |
| EP-1938795-A2 | Hair treatment composition, hair treatment agent and method for treating hair by using the same | Sunbio, Inc. (KR) | 2008-07-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080159975-A1 | Hair treatment composition, hair treatment agent and method for treating hair by using the same | KRT18, CUTA, KRTCAP2 | PSMB8 1560/4885PSMB5 1049/4885KDM6B 157/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.